Carlsbad, CA, United States of America

Jonathan J Hebert

This inventor holds 3 USPTO granted patents. Top assignee: Allergan, Inc.. Active years: 2004-2009.


% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2004-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Jonathan J Hebert

Introduction

Jonathan J Hebert is a notable inventor based in Carlsbad, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of kinase inhibitors. With a total of 3 patents to his name, Hebert's work focuses on addressing critical health issues through innovative solutions.

Latest Patents

One of his latest patents involves the development of organic molecules capable of modulating tyrosine kinase signal transduction. This invention aims to regulate, modulate, and inhibit abnormal cell proliferation, which is crucial in the treatment of various diseases. The patent emphasizes the importance of targeting specific pathways to improve therapeutic outcomes.

Career Highlights

Jonathan J Hebert is currently associated with Allergan, Inc., a leading company in the pharmaceutical industry. His role at Allergan allows him to leverage his expertise in biotechnology to contribute to the development of groundbreaking treatments. His work has been instrumental in advancing the understanding of kinase inhibitors and their applications in medicine.

Collaborations

Hebert has collaborated with notable colleagues, including Steven Wade Andrews and Michael E Garst. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to the advancement of their collective research efforts.

Conclusion

Jonathan J Hebert's contributions to the field of biotechnology through his patents and work at Allergan, Inc. highlight his commitment to improving healthcare solutions. His innovative approach to developing kinase inhibitors showcases the potential for significant advancements in the treatment of diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…